Rosetta Genomics Proceeds on Reverse Stock Split to Satisfy Nasdaq Requirements

The company is doing the reverse split to meet a minimum listing requirement of $1 per share.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories